Review explores cell-based immunotherapies for sepsis

Cell-based therapies can potentially restore normal immune function and treat organ failure in sepsis. Medical researchers have embarked on clinical trials and pre-clinical studies to investigate the efficacy and safety of such therapies, signaling a promising new avenue in sepsis treatment. Credit: Professor Xiangming Fang of Zhejiang University, China Imagine the human body mounting an excessively heightened reaction to an infection, causing multiple organ failures and posing a risk of death. This condition, recognized as sepsis, affects approximately 49 million individuals worldwide annually. To reduce the mortality rate and the Read More